Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07725055) titled 'AOSLO Imaging for the Study of Cellular Alterations in Retinal Neurodegeneration' on July 21.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Other. Masking: None (Open Label).
Primary Sponsor: Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Condition:
Glaucoma Associated With Other Ocular Disorders
Retina Disorder
Intervention:
Device: MONA Imaging System
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: September 2026
Target Sample Size: 260
To know more, visit https://clinicaltrials.gov/study/N...